Difficulty Continuing the Healthcare Business and Impairment of Related Fixed Assets
First written in FY2022-Q3. 1 of 2 entries say "Restated". Latest entry: FY2022.
0 other companies' latest entry also says "Restated".
- FY2022RestatedAnnual report
「In light of the extremely uncertain outlook for future demand due to substantial changes in the market environment and other factors, and the extreme difficulty of continuing the business, the Company recognized an impairment loss of ¥919 million on all fixed assets invested in the Healthcare business as an extraordinary loss.」
The Company continued to express a severely negative view of the demand outlook and the continuity of the Healthcare business, and recognized a ¥919 million impairment loss on related fixed assets for the full year as well. - FY2022-Q3First statedAnnual report
「In light of the extremely uncertain outlook for future demand due to substantial changes in the market environment and other factors, and the extreme difficulty of continuing the business, the Company recognized an impairment loss of ¥919 million on all fixed assets invested in the Healthcare business as an extraordinary loss.」
The Company indicated that the outlook for demand in the Healthcare business was extremely uncertain and that continuing the business would be extremely difficult, and recognized an impairment loss of ¥919 million on all fixed assets invested in the business.